InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

BSIF Insider Trading

Insider Ownership Percentage: 0.38%
Insider Buying (Last 12 Months): £55,746.25
Insider Selling (Last 12 Months): GBX 0

Bluefield Solar Income Fund Insider Trading History Chart

This chart shows the insider buying and selling history at Bluefield Solar Income Fund by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bluefield Solar Income Fund Share Price & Price History

Current Price: GBX 99.10
Price Change: ▼ Price Decrease of -0.6 (-0.60%)
As of 04/19/2024 05:36 PM ET

This chart shows the closing price history over time for BSIF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Secret Bull Market Starts in This Unusual Sector
From Altimetry   |   Ad
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Click for my No. 1 investment, all free of charge, click here. 

Bluefield Solar Income Fund Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2024Christopher WaldronInsiderBuy10,000GBX 100£10,000
3/25/2024Michael GibbonsInsiderBuy10,000GBX 99£9,900
3/15/2024Michael GibbonsInsiderBuy10,000GBX 103£10,300
2/28/2024Christopher WaldronInsiderBuy15,000GBX 104£15,600
8/23/2023John ScottInsiderBuy9,125GBX 109£9,946.25
12/8/2022John ScottInsiderBuy25,000GBX 138£34,500
12/1/2022John ScottInsiderBuy25,000GBX 138£34,500
10/20/2022John ScottInsiderBuy11,982GBX 125£14,977.50
10/14/2022John ScottInsiderBuy20,325GBX 123£24,999.75
10/6/2022John RennocksInsiderBuy30,000GBX 131£39,300
6/7/2022John ScottInsiderSell30,876GBX 130£40,138.80
2/24/2022John RennocksInsiderSell35,000GBX 121£42,350
See Full Table
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

SEC Filings (Institutional Ownership Changes) for Bluefield Solar Income Fund (LON:BSIF)

59.51% of Bluefield Solar Income Fund stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bluefield Solar Income Fund logo
Bluefield Solar Income Fund Ltd. is a close ended balanced mutual fund launched by Numis Securities Limited. The fund is managed by Bluefield Partners LLP. It invests the United Kingdom. The fund primarily invests in large-scale, long-life solar photovoltaic energy infrastructure assets with a focus on utility-scale assets and portfolios on greenfield, industrial and commercial sites through equity and/or debt instruments. Bluefield Solar Income Fund Ltd. was formed on July 12, 2013 and is domiciled in Guernsey, Channel Islands.
Read More on Bluefield Solar Income Fund

Today's Range

Now: GBX 99.10
Low: 99.10
High: 100.80

50 Day Range

MA: GBX 101.44
Low: 97.60
High: 105

52 Week Range

Now: GBX 99.10
Low: 96.80
High: 138.80

Volume

855,159 shs

Average Volume

1,393,134 shs

Market Capitalization

£605.95 million

P/E Ratio

330.33

Dividend Yield

6.17%

Beta

0.16

Who are the company insiders with the largest holdings of Bluefield Solar Income Fund?

Bluefield Solar Income Fund's top insider shareholders include:
  1. Christopher Waldron (Insider)
  2. John Rennocks (Insider)
  3. John Scott (Insider)
  4. Michael Gibbons (Insider)
Learn More about top insider investors at Bluefield Solar Income Fund.
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>